Lemmy Today

1,493 readers
74 users here now

Welcome to lemmy.today!

About us

🤗 Thanks for joining our little instance here, located in Oregon. The idea is to have a fast, stable instance and allow users to subscribe to whatever content they want from here.

😎 We dont block any other instances. We will keep it that way unless it becomes a moderation problem.

🤠 We will be around for a very long time, so you dont have to worry about us shutting down the instance anytime soon. We like performance and stability in our servers, and will upgrade the instance when its needed.

🥹 Make sure to join a lot of remote communities to get a good feed going. How to do that is explained here.

Lemmy mobile apps

You should start using one of these ASAP since the web browser user interface is quite ugly, even with themes.

Sync for Lemmy (Android)
Boost for Lemmy (Android)
Eternity (Android)
Liftoff (Android and IOS)
Voyager (IOS)
Voyager WebApp
Jerboa (Android)
Connect (Android)
Thunder (Android and IOS)
Mlem (IOS)
Memmy (IOS)

Optional Lemmy web browser user interfaces

Rules

Be respectful. Everyone should feel welcome here.
No bigotry - including racism, sexism, ableism, homophobia, transphobia, or xenophobia.
No Ads / Spamming, or creating communities to promote blogs or services.
No local pornography communities (but you are free to subscribe to them on other instances if you wish).
No local communities about software related to porn.
No local religious communities (use remote ones)

Contact the admin

@mrmanager

founded 1 year ago

ADMINS

mrmanager

Buelldozer

FDA approves blood test to screen for colon cancer (www.nbcnews.com)

submitted 1 month ago by return2ozma@lemmy.world to c/news@lemmy.world

6 comments fedilink

FDA approves new blood test to screen for colon cancer (www.nbcnews.com)

submitted 1 month ago by MicroWave@lemmy.world to c/health@lemmy.world

0 comments fedilink

The new test could increase the number of people screened for colorectal cancer, especially among adults too young for routine colonoscopies.

The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer. The test isn't meant to replace colonoscopies, but is generating enthusiasm among doctors who say it has the potential to boost the dismal rate of screenings for the second-highest cause of cancer death in the United States.

Shield has previously been available to doctors as a screening tool, at an out-of-pocket cost of $895. With the FDA approval, Medicare and private insurance companies are much more likely to cover the cost of the blood test, making it more widely accessible for patients.

Dr. Arvind Dasari, an associate professor in the department of gastrointestinal and medical oncology at the University of Texas MD Anderson Cancer Center, called the approval a “welcome development.”